S1 Episode 6: New and Emerging Therapies in HIV Treatment

S1 Episode 6: New and Emerging Therapies in H...

Up next

S2 Episode 1: Anticipating and Managing Drug Interactions: Pharmacokinetics of Long-Acting HIV Treatment and Prevention Formulations

Drs Michael S. Saag and Charles W. Flexner discuss the mechanisms of drug-drug interactions and the promise and limitations of longer-acting HIV therapeutics for both treatment and prevention. Relevant disclosures can be found with the episode show notes on Medscape ( https://www. ...  Show more

S2 Episode 2: When Viral Pandemics Collide: Vaccinating, Boosting and Caring for Patients Diagnosed With HIV During the Time of COVID

Drs Michael S. Saag and Monica Gandhi discuss COVID-19 and the impact this pandemic has had on patients diagnosed with HIV, including vaccines, boosters, and patients who are older or have chronic comorbid conditions. Relevant disclosures can be found with the episode show notes ...  Show more

Recommended Episodes

123: Lenacapavir for HIV Prevention
Febrile

Drs. Anshel Kenkare and Mike Reid share a conversation about the incredible science and current context of lenacapavir for HIV prevention, which was recently approved by the FDA.Episodes | Consult Notes | Subscribe | Twitter | Merch | febrilepodcast@gmail.comFebrile is produced w ...  Show more

Episode 5: Crash-Course in infectious diseases for psychiatrists treating people living with HIV/AIDS
Topics in Consultation-Liaison Psychiatry

In this episode, our host, Dr. Paulo Sales, interviews Dr. Mike Saag to condense high-yield information on infectious diseases that the consultation-liaison psychiatrist should be aware of. Among other topics, Dr. Saag discusses the recent advances in Mpox and the role of vaccina ...  Show more

New Research: Mitochondrial DNA in TRALI and Venetoclax-Obinituzumab in CLL Trials
Blood Podcast

In this week's episode, associate editor Dr. James Griffin interviews researchers Dr. John Semple and Dr. Othman Al-Sawaf on their groundbreaking studies on transfusion-related acute lung injury and chronic lymphocytic leukemia treatment. Dr. Semple explored how mitochondrial DNA ...  Show more

Trial of the Week: PROWESS-SHOCK
Pharmacy to Dose: The Critical Care Podcast

Trial of the Week: PROWESS-SHOCKSpecial Guest: Paul Szumita, PharmD, FCCM, FASHP, BCCCP, BCPS @paulszumita 03:30 – Background studies/Setting the scene30:25 – PROWESS-SHOCK discussion/Where are we now Paul Szumita joins to highlight a June Trial of the Week “Drotrecogin alfa (act ...  Show more